“clovis-oncology” Archives

in
Entry Author Date Location
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs 04/09/20 Boston
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug 10/15/19 Boston
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More 10/01/19 National
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer 02/26/19 New York
GSK Pays $5.1B For Tesaro, Setting Up “PARP” Battle With Rival AstraZeneca 12/03/18 Boston
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
AstraZeneca’s PARP Drug Is First to Help New Ovarian Cancer Patients 06/27/18 National
Cyteir Bags $29M to Tap “Self Destruct” in Cancers, Immune Diseases 03/08/18 Boston
Moderna Ends “Venture” Experiment, Dissolves Four Startups 09/14/17 Boston
On Drug Pricing: FDA Backs Up Its Calls for Increased Competition 08/21/17 San Diego
Tesaro Cashes In Again on PARP Blocker With $100M Takeda Deal 07/27/17 Boston
Bio Roundup: Senate Trumpcare, FDA On Cancer, Alzheimer Review & More 06/23/17 National
Repare Nabs $68M To Find Synthetic Lethal Cancer Targets Beyond PARP 06/22/17 Boston
New Ovarian Cancer Data Suggests Larger Role For Top Clovis Drug 06/19/17 Boulder/Denver
Tesaro’s Ovarian Cancer Drug Gets FDA Nod, No Diagnostic Needed 03/27/17 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug 12/19/16 Boulder/Denver
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer 03/03/16 Boston
Clovis Oncology Shares Plummet on FDA Request for More Data 11/16/15 Boulder/Denver
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
Clovis Shares Drop Following Release of Cancer-Drug Trial Data 11/19/14 Boulder/Denver
Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat 06/06/14 Boston
Clovis Shares Tumble as Analysts Give Edge to Lung-Cancer Rival 06/04/14 Boulder/Denver
New Venture Funds, Sympoz’s Big Score are Top Colorado Stories for 4Q 01/02/14 Boulder/Denver
Biodesix Closes $8.3M Round, New Clovis Shareholders Begin Selling 12/03/13 Boulder/Denver
Clovis Oncology CEO Mahaffy Opens Up About Company’s Turbulent Year 10/17/13 Boulder/Denver
Page 1 of 2 next page »